VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 122 filers reported holding VERVE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,183,430 | -28.0% | 466,322 | +1.8% | 0.00% | -50.0% |
Q2 2023 | $8,591,963 | +47.6% | 458,238 | +13.5% | 0.00% | +100.0% |
Q1 2023 | $5,819,378 | -24.8% | 403,563 | +0.9% | 0.00% | -50.0% |
Q4 2022 | $7,737,349 | -42.1% | 399,863 | +2.8% | 0.00% | -33.3% |
Q3 2022 | $13,358,000 | +211.2% | 388,916 | +38.4% | 0.00% | +200.0% |
Q2 2022 | $4,292,000 | -32.7% | 280,915 | +0.5% | 0.00% | 0.0% |
Q1 2022 | $6,378,000 | +19.6% | 279,499 | +93.3% | 0.00% | 0.0% |
Q4 2021 | $5,331,000 | -19.0% | 144,585 | +3.2% | 0.00% | 0.0% |
Q3 2021 | $6,584,000 | – | 140,091 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alphabet Inc. | 10,974,011 | $515,778,000 | 12.24% |
Casdin Capital, LLC | 3,038,167 | $142,794,000 | 3.55% |
Redmile Group, LLC | 1,869,030 | $87,844,000 | 1.53% |
Logos Global Management LP | 443,265 | $20,833,000 | 1.50% |
Novo Holdings A/S | 600,000 | $28,200,000 | 1.46% |
Cormorant Asset Management, LP | 709,224 | $32,667,000 | 1.33% |
Rock Springs Capital Management LP | 962,826 | $45,253,000 | 0.95% |
HighVista Strategies LLC | 18,782 | $883,000 | 0.58% |
RA Capital Management | 880,284 | $41,373,000 | 0.57% |
Nicholas Investment Partners, LP | 132,300 | $6,218,000 | 0.45% |